Results 1 to 10 of about 79,524 (248)

Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study [PDF]

Vaccines
Objective: To assess changes in disease activity in Multiple Sclerosis (MS) patients on various disease-modifying-drugs, as well as immunogenicity, safety and clinical tolerability following combined tetanus- and diphtheria-vaccination.
Alexander Winkelmann, Emil C. Reisinger, Katharina Boden, Christoph Metze, Uwe K. Zettl, Micha Loebermann   +5 more
doaj   +3 more sources

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population [PDF]

BMC Infectious Diseases, 2021
Background Despite high childhood immunization coverage, sporadic cases of diphtheria have been reported in Malaysia in recent years. This study aims to evaluate the seroprevalence of diphtheria among the Malaysian population.
Ahmad Faudzi Yusoff, Zatil Zahidah Mohd Sharani, Chee Cheong Kee, Nuur Hafizah Md Iderus, Ahmed Syahmi Syafiq Md Zamri, Tharmarajah Nagalingam, Mohd Safrin Mohamad Bashaabidin, Wan Abdul Hannan Wan Ibadullah, Sumarni Mohd Ghazali, Ainur Yusniza Yusof, Yee Ming Ching, Nurhanani Mohamed Nor, Balqis Kamarudin, Norazah Ahmad, Masita Arip   +14 more
doaj   +3 more sources

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019. [PDF]

MMWR Morb Mortal Wkly Rep, 2020
Since 2005, a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine has been recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and adults (1,2).
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H.   +4 more
europepmc   +2 more sources

Seroprevalence of anti-diphtheria toxoid antibody and implications for vaccination policy in Vietnam’s South-central coast: a cross-sectional study [PDF]

BMC Infectious Diseases
Background Diphtheria is a re-emerging infectious disease and public health concern worldwide and in Vietnam with increasing cases in recent years. This study aimed to assess the anti-diphtheria toxoid antibodies status in Khanh Hoa Province and identify
Hoang Thieu Le, Thai Hung Do, The Anh Dao, Tien Thanh Hoang, Bao Trieu Nguyen, Thuy Lien Le, Dinh Luong Nguyen, Lay-Myint Yoshida, Xuan Huy Le, Hong Quan Le, That Toan Ton, Min Jin Ha   +11 more
doaj   +2 more sources

Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. [PDF]

Vaccine, 2018
Objective: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertusiss (Tdap) vaccine is recommended during each pregnancy, regardless of prior receipt. Data on reactogenicity and immunogenicity, particularly after repeated Tdap, are limited.
Fortner KB, Swamy GK, Broder KR, Jimenez-Truque N, Zhu Y, Moro PL, Liang J, Walter EB, Heine RP, Moody MA, Yoder S, Edwards KM.   +11 more
europepmc   +2 more sources

Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles. [PDF]

Pharm Res, 2018
To examine the immunogenicity of diphtheria toxoid (DT) loaded mesoporous silica nanoparticles (MSNs) after coated and hollow microneedle-mediated intradermal immunization in mice.
Du G, Woythe L, van der Maaden K, Leone M, Romeijn S, Kros A, Kersten G, Jiskoot W, Bouwstra JA.   +8 more
europepmc   +2 more sources

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. [PDF]

Pharmacoepidemiol Drug Saf, 2018
In light of waning immunity to pertussis following receipt of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine, maintaining protection may require repeated Tdap vaccination.
Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA.   +10 more
europepmc   +2 more sources

Augmentation of IL-21 and soluble CD14 in systemic aspergillosis through combined immunostimulation with beta-glucan and diphtheria toxoid [PDF]

Open Veterinary Journal
Background: Aspergillus fumigatus leads to serious systemic infections in immunocompromised patients, thereby emphasizing the need for novel immunomodulatory therapies acting on both innate (sCD14) and adaptive (IL-21) immune systems.
Mustafa Abdul Kareem Hameed, Huda Sadoon Jassim Al Biaty, Sabah Zyara Kadhim   +2 more
doaj   +2 more sources

Summary of the NACI Update on Immunization in Pregnancy with Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Acellular Pertussis (Tdap) Vaccine. [PDF]

Can Commun Dis Rep, 2018
Background In Canada, pertussis is an endemic and cyclical disease, with peaks occurring at two- to five-year intervals. Although pertussis incidence varies by age group, unvaccinated or undervaccinated infants are at greatest risk of infection and ...
Brophy J, Baclic O, Tunis MC.
europepmc   +2 more sources

Development of a quality control test for diphtheria vaccine based on an electrochemical aptamer-based biosensor [PDF]

Scientific Reports
At every stage of the vaccine’s development, including research and development together with the routine production (in-process control of batch release), quality control testing is a crucial operation for ensuring the efficacy, safety and consistency ...
Abrar Almusharraf, Amina Rhouati, Dana Cialla-May, Jürgen Popp, Mohammed Zourob   +4 more
doaj   +2 more sources